Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2022 Filed Mar 16, 2022 02:00 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 78,043 | $5.04 | $393,305.50 |
DisclosureSEC source: 0001209191-22-019066 · doc4.xml · nonDerivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,885,141 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:59 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 10,185 | $5.04 | $51,327.31 |
DisclosureSEC source: 0001209191-22-019065 · doc4.xml · nonDerivative · entry 6 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,414 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:59 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 15,398 | $5.04 | $77,599.76 |
DisclosureSEC source: 0001209191-22-019065 · doc4.xml · nonDerivative · entry 4 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,599 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:59 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 16,151 | $5.04 | $81,392.96 |
DisclosureSEC source: 0001209191-22-019065 · doc4.xml · nonDerivative · entry 2 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,097 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
SaleCommon Stock | 5,982 | $5.04 | $30,146.89 |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 6 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,126,716 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
SaleCommon Stock | 8,173 | $5.04 | $41,188.65 |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,116,031 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
SaleCommon Stock | 16,152 | $5.04 | $81,399.62 |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,101,434 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:55 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 7,777 | $5.04 | $39,192.19 |
DisclosureSEC source: 0001209191-22-019063 · doc4.xml · nonDerivative · entry 6 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,334 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:55 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 8,173 | $5.04 | $41,188.65 |
DisclosureSEC source: 0001209191-22-019063 · doc4.xml · nonDerivative · entry 4 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,444 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:55 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 16,152 | $5.04 | $81,399.62 |
DisclosureSEC source: 0001209191-22-019063 · doc4.xml · nonDerivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,847 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:50 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 5,982 | $5.04 | $30,146.89 |
DisclosureSEC source: 0001209191-22-019062 · doc4.xml · nonDerivative · entry 6 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,665 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:50 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 8,173 | $5.04 | $41,188.65 |
DisclosureSEC source: 0001209191-22-019062 · doc4.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,980 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:50 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 16,152 | $5.04 | $81,399.62 |
DisclosureSEC source: 0001209191-22-019062 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,383 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 22:29 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 4,188 | $5.04 | $21,106.26 |
DisclosureSEC source: 0001209191-22-019303 · doc4.xml · nonDerivative · entry 6 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,268 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 22:29 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 8,173 | $5.04 | $41,188.65 |
DisclosureSEC source: 0001209191-22-019303 · doc4.xml · nonDerivative · entry 4 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,789 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 22:29 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 16,152 | $5.04 | $81,399.62 |
DisclosureSEC source: 0001209191-22-019303 · doc4.xml · nonDerivative · entry 2 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,192 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 22:25 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 5,982 | $5.04 | $30,146.89 |
DisclosureSEC source: 0001209191-22-019301 · doc4.xml · nonDerivative · entry 6 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,871 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 22:25 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 8,173 | $5.04 | $41,188.65 |
DisclosureSEC source: 0001209191-22-019301 · doc4.xml · nonDerivative · entry 4 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,186 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 22:25 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 16,152 | $5.04 | $81,398.00 |
DisclosureSEC source: 0001209191-22-019301 · doc4.xml · nonDerivative · entry 2 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,589 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 02:00 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 64,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019066 · doc4.xml · derivative · entry 9 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,333 Underlying: Common Stock · 64,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 02:00 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 104,362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019066 · doc4.xml · derivative · entry 8 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,525 Underlying: Common Stock · 104,362 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F6 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 02:00 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 151,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019066 · doc4.xml · derivative · entry 7 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 151,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 02:00 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 64,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019066 · doc4.xml · nonDerivative · entry 5 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 02:00 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 104,362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019066 · doc4.xml · nonDerivative · entry 3 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,989,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 02:00 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 151,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019066 · doc4.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,963,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:59 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019065 · doc4.xml · derivative · entry 9 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:59 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 42,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019065 · doc4.xml · derivative · entry 8 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,200 Underlying: Common Stock · 42,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F6 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:59 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019065 · doc4.xml · derivative · entry 7 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:59 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019065 · doc4.xml · nonDerivative · entry 5 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:59 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionCommon Stock | 42,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019065 · doc4.xml · nonDerivative · entry 3 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:59 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019065 · doc4.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · derivative · entry 9 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · derivative · entry 8 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,460 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F6 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · derivative · entry 7 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 5 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,132,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,124,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,117,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:55 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 21,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019063 · doc4.xml · derivative · entry 9 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,333 Underlying: Common Stock · 21,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:55 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019063 · doc4.xml · derivative · entry 8 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,460 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F6 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:55 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019063 · doc4.xml · derivative · entry 7 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:55 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 21,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019063 · doc4.xml · nonDerivative · entry 5 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:55 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019063 · doc4.xml · nonDerivative · entry 3 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:55 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019063 · doc4.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:50 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019062 · doc4.xml · derivative · entry 9 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:50 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019062 · doc4.xml · derivative · entry 8 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,460 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F6 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:50 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019062 · doc4.xml · derivative · entry 7 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:50 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionCommon Stock | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019062 · doc4.xml · nonDerivative · entry 5 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:50 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionCommon Stock | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019062 · doc4.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:50 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019062 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:29 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019303 · doc4.xml · derivative · entry 9 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,333 Underlying: Common Stock · 11,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.